Comerica Bank
CBAY

Comerica Bank’s Cymabay Therapeutics CBAY Stock Holding History

Comerica Bank’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-69,260
Closed -$1.64M – 3843
2023
Q4 		$1.64M Buy
69,260
+67,907
+5,019% +$1.21M 0.01% 1280
2023
Q3 		$20.2K Buy
+1,353
New +$17.9K ﹤0.01% 3006

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Comerica Bank's CBAY Position: Q1 2024 in Review

Comerica Bank sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 69,260 shares — an estimated $1.64M sold.

Comerica Bank first reported a position in CBAY in Q3 2023 and held it in 2 quarters. The position peaked at $1.64M in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

  • Comerica Bank reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Comerica Bank sold 69,260 Cymabay Therapeutics shares in Q1 2024, an estimated $1.64M.
  • Comerica Bank first reported a position in Cymabay Therapeutics in Q3 2023 and held it in 2 quarters.
  • Comerica Bank's Cymabay Therapeutics position peaked at $1.64M in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Comerica Bank's 13F filing for Q1 2024, filed 16 May 2024.